ANGEL ROBERSON: Open Payments
NPI 1497477608 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 45 payments from 13 companies in 2025. Trend: 2023 $563 · 2024 $646 · 2025 $1,197
Food & beverage: $1,103Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $526 |
| ABBVIE INC. | 9 | $280 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| PFIZER INC. | 2 | $36 |
| Genentech USA, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $20 |
Products named: TREMFYA, SKYRIZI, RINVOQ, ENTYVIO, DUPIXENT, IQIRVO, Venclexta, CREON.
Industry payments across IN — which companies pay providers there.
